P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study

Post time 2024-6-14 09:04:29

journal：JACC: Cardiovascular Interventions

Authors：Luis Ortega-Paz; Wilbert Bor; Francesco Franchi; Wout W.A. van de Broek; Fabiana Rollini; Salvatore Giordano; Mattia Galli; Latonya Been; Ghussan Ghanem; Awss Shalhoub; Haroutioun Garabedian; Tala Al Saleh; Ekin Uzunoglu; Xuan Zhou; Andrea Rivas; Andres M. Pineda; Siva Suryadevara; Daniel Soffer; Madeline K. Mahowald; Calvin Y. Choi; Martin M. Zenni; Fladia Phoenix; Ramzi A. Ajjan; Jurrien M. ten Berg; Dominick J. Angiolillo

Published date：2024-4-

DOI：10.1016/j.jcin.2024.03.027

PDF link：https://www.sciencedirect.com/sc ... 936879824006319/pdf

Article link：http://dx.doi.org/10.1016/j.jcin.2024.03.027

Article Source：Elsevier BV。

Remark：

Post time 2024-6-14 09:04:30

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study